ClinicalTrials.Veeva

Menu

Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy

K

Khon Kaen University

Status and phase

Enrolling
Phase 3
Phase 2

Conditions

Laparoscopic Sleeve Gastrectomy
Bupivacine
Opioid Use
Morbid Obesity
Local Wound Infiltration
Transversus Abdominis Plane Block

Treatments

Procedure: Local wound infiltration
Procedure: peri-wound Transversus Abdominis Plane Block

Study type

Interventional

Funder types

Other

Identifiers

NCT05930184
HE651586

Details and patient eligibility

About

The goal of this randomized controlled trial is to compare laparoscopic guided peri-wound Transversus Abdominis Plane Block and bupivacaine versus local wound infiltration effect on reducing post-op opioid use in Laparoscopic Sleeve gastrectomy. The main questions it aims to answer are:

• Can laparoscopic guided peri-wound Transversus Abdominis Plane Block reduced post operative morphine usage when comparing with local wound port site infiltration.

Participants will be randomize into 2 group

  • peri-wound Transversus Abdominis Plane Block
  • local wound port site infiltration

Enrollment

98 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient undergoing LSG at Sringarind hospital as indicated by Thai guideline

Exclusion criteria

  • Allergic/contraindicated to bupivacaine, morphine, fentanyl, NSAIDs or Nefopam
  • Unable to describe pain score Opioid addict
  • denied consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

98 participants in 2 patient groups

local wound infiltration
Active Comparator group
Description:
0.25% Bupivacaine 20ml was injected into the wound subcutaneous tissue after the laparoscopic port was removed
Treatment:
Procedure: Local wound infiltration
peri-wound Transversus Abdominis Plane Block
Experimental group
Description:
0.25% Bupivacaine 20ml was injected into the transversus abdominis plane around the wound before the laparoscopic port was removed
Treatment:
Procedure: peri-wound Transversus Abdominis Plane Block

Trial contacts and locations

1

Loading...

Central trial contact

Thanatat Panitphong, Doctor of Medicine; Suriya Punchai, Assistant Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems